|
331 |
First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial
Enthalten in Liver cancer Bd. 14, 2024, Nr. 4: 365-377. 13 S.
|
|
|
|
332 |
Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study
Enthalten in Cardiorenal Medicine Bd. 14, 2024, Nr. 1: 160-166. 7 S.
|
|
|
|
333 |
A Systematic Search and Review of Registered Pharmacological Therapies Investigated to Improve Outcomes after a Stroke
Enthalten in Cerebrovascular diseases / Extra Bd. 14, 2024, Nr. 1: 158-164. 7 S.
|
|
|
|
334 |
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394
Enthalten in Liver cancer Bd. 13, 2024, Nr. 4: 389-400. 12 S.
|
|
|
|
335 |
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammation
Enthalten in Pharmacopsychiatry 20.12.2024
|
|
|
|
336 |
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
Enthalten in Neuropsychopharmacology 19.12.2024: 1-9
|
|
|
|
337 |
Efficacy and safety of tenapanor vs placebo in treating CKD patients on dialysis and with hyperphosphatemia: a systematic review and meta-analysis of 2251 patients
Enthalten in International urology and nephrology 19.12.2024: 1-16
|
|
|
|
338 |
Medications for Opioid Use Disorder Helpful or Placebo? An Evaluation of the Effectiveness of MOUD in Carceral Settings
Enthalten in American journal of criminal justice 18.12.2024: 1-22
|
|
|
|
339 |
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: A Meta-analysis of Randomized Placebo-Controlled Trials
Enthalten in American journal of cardiovascular drugs 16.12.2024: 1-11
|
|
|
|
340 |
The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 16.12.2024: 1-11
|
|
Administration
